University of Edinburgh

Final analysis of the ALTTO trial: adjuvant trastuzumab in sequence or in combination with lapatinib in patients with HER2-positive early breast cancer [BIG 2-06/NCCTG N063D (Alliance)] (2024) de Azambuja E, Piccart-Gebhart M, Fielding S, Townend J, Hillman DW, Colleoni M, Roylance R, et al. Journal article Expansion of the neurodevelopmental phenotype of individuals with EEF1A2 variants and genotype-phenotype study (2024) Paulet A, Bennett-Ness C, Ageorges F, Trost D, Green A, Goudie D, Jewell R, et al. Journal article Sedimentología para la transición energética: proyecto SOSGAS, un ejemplo de flujo de trabajo para la evaluación de calidad de reservorios (2024) Viseras C, Cabello P, Yeste LM, Alcalde J, López-Blanco M, Cuevas JL, Gil-Ortiz M, et al. Journal article Decompressive craniectomy plus best medical treatment versus best medical treatment alone for spontaneous severe deep supratentorial intracerebral haemorrhage: a randomised controlled clinical trial (2024) Beck J, Fung C, Strbian D, Bütikofer L, Z'Graggen WJ, Lang MF, Beyeler S, et al. Journal article Corrigendum to “European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines” [Eur. Urol. 85 (2024) 17–31, (S0302283823030737), (10.1016/j.eururo.2023.08.016)] (2024) Alfred Witjes J, Bruins HM, Carrión A, Cathomas R, Compérat E, Efstathiou JA, Fietkau R, et al. Journal article, Erratum Disease-free survival as a surrogate for overall survival in HR+/HER2– early breast cancer: A correlation analysis (2024) Untch M, Pérol D, Mayer EL, Cortes J, Nusch A, Cameron D, Barrios C, et al. Journal article Integral representations for the double-diffusivity system on the half-line (2024) Chatziafratis A, Aifantis EC, Carbery A, Fokas AS Journal article Poorly differentiated thyroid carcinomas: conceptual controversy and clinical impact (2024) Coca-Pelaz A, Rodrigo JP, Agaimy A, Williams MD, Saba NF, Nuyts S, Randolph GW, et al. Journal article, Review article Identification of Patients with Early HR+ HER2- Breast Cancer at High Risk of Recurrence (2024) Fasching P, Kreipe H, Del Mastro L, Ciruelos E, Freyer G, Korfel A, Chouaki N, et al. Journal article, Review article Metrics reloaded: recommendations for image analysis validation (2024) Maier-Hein L, Reinke A, Godau P, Tizabi MD, Buettner F, Christodoulou E, Glocker B, et al. Journal article